检索

标题
作者
Neural networks in the predictive diagnosis of cognitive impairment in type 1 and type 2 diabetes mellitus
Samoilova I., Matveeva M., Kudlay D., Tonkikh O., Tolmachev I.
Finerenone cardiorenal effects and its placement in treatment of chronic kidney disease in patients with type 2 diabetes mellitus: A review
Salukhov V., Shamkhalova M., Duganova A.
Non-alcoholic fatty liver disease and type 2 diabetes mellitus: general approaches to the choice of therapy
Petunina N., Telnova M., Goncharova E., Martirosian N., Kuzina I.
Features of the course of COVID-19 in patients with type 2 diabetes mellitus
Karaseva E., Martynov V., Filatova T., Maleev V., Grishin V., Pronin N., Verbitskaya E., Popova V.
Diabetes mellitus type 2: National Russian guidelines vs real clinical practice
Shestakova M., Vikulova O., Zheleznyakova A., Dedov I., Mokrysheva N.
Long-term uroseptic and metabolic effects of a herbal medicinal preparation in women with type 2 diabetes taken gliflosins
Tsygankova O., Timoshchenko O., Apartseva N., Latyntseva L.
The effect of a medicinal plant preparation on the frequency of episodes of exacerbation of recurrent cystitis and metabolic parameters in patients with type 2 diabetes mellitus taking glyphlosins
Tsygankova O., Evdokimova N., Timoshchenko O., Latyntseva L.
Adipokines and the cardiorespiratory system in young patients with type 1 diabetes mellitus
Vengrzhinovskaya O., Bondarenko I., Shatskaya O., Nikankina l., Kalashnikov V., Shestakova M., Mokrysheva N.
Chronic kidney disease in outpatients with arterial hypertension: clinical characteristics and treatment efficacy (according to the national registry)
Oschepkova E., Aksenova A., Orlovsky A., Chazova I.
SGLT2 inhibitors in acute decompensated heart failure, what do we know?
Lapteva A., Nasonova S., Zhirov I., Tereshchenko S.
Advantages of glucagon-like peptide-1 receptor agonists in the treatment of patients with type 2 diabetes mellitus: A review
Demidova T., Titova V., Izmaylova M.
Type 2 diabetes mellitus and coronary artery disease: features of perfusion volume computed tomography of the heart in a pharmacological test with adenosine triphosphate
Soboleva G., Minasyan A., Gaman S., Rogoza A., Molina L., Soboleva T., Shariya M., Ternovoy S., Karpov Y.
Comparative analysis of the drugs efficacy for carbohydrate metabolism early disorders (prediabetes) treatment: A review
Mkrtumyan A.
Ala54Thr polymorphism of the fatty acid transporter gene (FABP2) in patients with type 2 diabetes mellitus in Yakutia
Sydykova L., Pavlova N., Bochurov A., Alekseev V., Krylov A., Kurtanov K., Shestakova M.
Clinical importance of evaluation of circulating miRNA expression and epicardial adipose tissue thickness as predictors of cardiovascular pathology in young patients with type 1 diabetes mellitus
Vengrzhinovskaya O., Bondarenko I., Shatskaya O., Tarbaeva N., Korneluk A., Kalashnikov V., Shestakova M., Mokrysheva N.
Resolution of the Expert Forum "New therapeutic horizons of NAFLD"
Drapkina O., Martynov A., Arutyunov G., Bakulin I., Livzan M., Maev I., Egorov I.
Pharmacogenetics of dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes mellitus: A review
Samoilova I., Vaizova O., Stankova A., Matveeva M., Podchinenova D., Kudlay D., Borozinets A., Filippova T., Grishkevich I., Partala A., Gerasimova D.
Clinical effectiveness and pharmacokinetics of gliflozin from the point of view of individual genetic characteristics: A review
Golovina E., Vaizova O., Meleshko M., Samoilova I., Podchinenova D., Borozinets A., Matveeva M., Kudlay D.
Possibilities for the use of ursodeoxycholic acid in the treatment of patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease
Rasskazova M., Vorobyev S., Butova H.
The attitude of patients with types 1 and 2 diabetes mellitus towards having the disease
Sapozhnikova I., Zotina E.
Polymorphic variants of glutathione reductase – new genetic markers of predisposition to type 2 diabetes mellitus
Azarova I., Klyosova E., Polonikov A.
Experience with "AlfaVit Diabetes" used in the treatment of diabetic peripheral polyneuropathy in adolescents
Azova E., Vorob'eva V., Chekalova S., Okulova O., Azov N., Kolbasina E., Belotserkovskaia O., Severukhina T., Sladkova I.
The degree of alexithymia in type 2 diabetes mellitus patients and its association with medical and demographic parameters
Sapozhnikova I., Tarlovskaia E., Madianov I., Vedenskaia T.
The prevalence of components of metabolic syndrome in the patients with diabetes melitus type 2 and mody diabetes in young people of Novosibirsk
Mustafina S., Ovsyannikova A., Voevoda M., Denisova D., Sherbakova L., Rymar O.
Acute coronary syndrome in patients with type 2 diabetes mellitus
Ametov A., P'yanykh O., Aslandziya E., Ametov A., Pianykh O., Aslandzia E.
Renal effects of glucagon-like peptide receptor agonists in patients with type 1 diabetes mellitus
Vikulova O., Zuraeva Z., Michaleva O., Nikankina L., Shamkhalova M., Shestakova M., Dedov I.
Urinary tract infections in patients with type 2 diabetes mellitus with pharmacological glucosuria
Sturov N., Popov S., Mamporia N., Mager A.
Cardio-ankle vascular index (CAVI) in diagnostics, risk and severity evaluation of magistral vessels lesion in patients with cardio-vascular diseases and type 2 diabetes
Verner V., Mel’nik M., Knjazeva S.
Non-alcoholic fatty liver disease and type 2 diabetes mellitus: issues of the liver fibrosis diagnostics
Anisonyan A., Sandler Y., Khaimenova T., Keyan V., Saliev K., Sbikina E., Vinnitskaya E.
Gene therapy of type 2 diabetes mellitus: state of art
Stafeev Y., Menshikov M., Parfyonova Y.
Nonglycemic effects of incretins in patients with long-term type 1 diabetes mellitus and chronic kidney disease
Arutyunova M., Glazunova A., Mikhaleva O., Zuraeva Z., Martynov S., Klefortova I., Manchenko O., Ulyanova I., Ilyin A., Shamkhalova M., Shestakova M.
Specific features of neurological complications developing in patients with type 2 diabetes mellitus and metabolic syndrome: Possibility for correction and prevention
Shishkova V.
Endothelial dysfunction is a target for combination antihypertensive therapy in hypertensive patients with type 2 diabetes mellitus
Statsenko M., Derevianchenko M., Ostrovskiĭ O., Titarenko M., Shvets M., Bondarev A.
Efficacy of pharmacological inhibition of intestinal saccharases in patients with diabetes mellitus type 2 and/or visceral obesity
Ametov A., Kamynina L., Ametov A., Kamynina L.
Contribution of obesity to renal lesion in patients with type 2 diabetes mellitus
Kutyrina I., Savelyeva S., Kryachkova A., Shestakova M.
Sex- and age-specific characteristics of arterial hypertension prevalence in type 2 diabetes mellitus patients with obesity
Kazymov M., Fishman B., Veber V., Fishman M., Kopina M., Kuprin P., Kazymov M., Fishman B., Veber V., Fishman M., Kopina M., Kuprin P.
Role of insulin resistance in pathogenesis of diabetes mellitus type 2
Balabolkin M., Klebanova E., hanov О., Lomonosov К.
Renal experiences of bariatric surgery in patients with type 2 diabetes mellitus
Larina I., Severina A., Shamkhalova M., Shestakova M.
Incretin secretion and glucose metabolism in morbidly obese patients in the early and late periods after biliopancreatic diversion
Dedov I., Melnichenko G., Troshina E., Ershova E., Mazurina N., Ogneva N., Yashkov Y., Ilyin А.
Chronic constipation in the practice of a therapist: Features of therapy for comorbidity
Svistunov A., Osadchuk M., Butorova L., Tokmulina G.
Intercurrent and autoimmune processes in type 1 diabetes mellitus
Derevyanko O., Nikonova T., Smirnova O., Dedov I.
Comparative analysis of the changing pattern of thyroid disease in patients with type 2 diabetes mellitus in the Perm Region after 10 years
Tereshchenko I., Suslina A.
A combination of dipeptidyl peptidase-4 inhibitor and metformin in the treatment of patients with type 2 diabetes mellitus: effective control of glycemia, weight, and quantitative body composition
Shestakova M., Sukhareva O., Chernova T., Shmushkovich I., Aleksandrov A., Il'in A., Dedov I.
Carbohydrate metabolic disturbances and obstructive sleep apnea syndrome
Oleĭnikov V., Sergatskaia N.
Pharmacogenetic features of the effect of metformin in patients with coronary heart disease in the presence of metabolic syndrome and type 2 diabetes mellitus in terms of PPAR-γ2 gene polymorphism
Lavrenko A., Shlykova O., Kutsenko L., Mamontova T., Kaĭdashev I.
Impact of insulin therapy on insulin resistance and a risk for coronary heart disease and cardiovascular death in patients with type 2 diabetes
Ametov A., Kochergina I., Ulanova K., Ametov A., Kochergina I., Ulanova K.
Immunomodulating, metabolic and cardioprotective effects of AT1-angiotensin receptors blocker losartan in patients with coronary heart disease and type 2 diabetes mellitus
Teplyakov A., Mayanskaya S., Bolotskaya L., Vdovina T., Stepacheva T., Kuznetsova A., Lukinov A., Derbeneva N., Frants M., Shilov S., Teplyakov A., Mayanskaya S., Bolotskaya L., Vdovina T., Stepacheva T., Kuznetsova A., Lukinov A., Derbeneva N., Frants M., Shilov S.
Metabolic syndrome of insulin resistance: basic conception and consequences (a review)
Starkova N., Dvoryashina I.
Prognostic factors for the carbohydrate metabolism normalization in patients with type 2 diabetes mellitus and obesity using liraglutide 3.0 mg per day
Sklyanik I., Shestakova M.
Gut microbiota is a factor of risk for obesity and type 2 diabetes
Demidova T., Lobanova K., Oinotkinova O.
1 - 50 的 119 信息 1 2 3 > >> 

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##